NCT07762573 Dynamic Functional Imaging Phenotyping and Disease Progression Risk Assessment in COPD Using Dynamic Chest Radiography: A Multicenter Retrospective Study
| NCT ID | NCT07762573 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanfang Hospital, Southern Medical University |
| Condition | Chronic Obstructive Pulmonary Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,500 participants |
| Start Date | 2026-08-03 |
| Primary Completion | 2029-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,500 participants in total. It began in 2026-08-03 with a primary completion date of 2029-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate the utility of DCR-derived parameters for identifying dynamic functional imaging phenotypes, assessing disease severity, and predicting the risk of disease progression in COPD.
Eligibility Criteria
Inclusion Criteria: 1. Aged 30-85 years. 2. Male or female. 3. Patients who underwent pulmonary function testing and dynamic chest radiography at the hospital. Exclusion Criteria: 1. Incomplete medical records. 2. Considered unsuitable for inclusion in the study at the investigator's discretion.
Contact & Investigator
Laiyu Liu, professor
STUDY CHAIR
Nanfang Hospital, Southern Medical University
Frequently Asked Questions
Who can join the NCT07762573 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 85 Years, studying Chronic Obstructive Pulmonary Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07762573 currently recruiting?
Yes, NCT07762573 is actively recruiting participants. Contact the research team at liulaiyu@sina.com for enrollment information.
Where is the NCT07762573 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT07762573 clinical trial?
NCT07762573 is sponsored by Nanfang Hospital, Southern Medical University. The principal investigator is Laiyu Liu, professor at Nanfang Hospital, Southern Medical University. The trial plans to enroll 2,500 participants.